Correlation Between Klaria Pharma and Nanexa AB

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Klaria Pharma and Nanexa AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Klaria Pharma and Nanexa AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Klaria Pharma Holding and Nanexa AB, you can compare the effects of market volatilities on Klaria Pharma and Nanexa AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Klaria Pharma with a short position of Nanexa AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Klaria Pharma and Nanexa AB.

Diversification Opportunities for Klaria Pharma and Nanexa AB

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Klaria and Nanexa is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Klaria Pharma Holding and Nanexa AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nanexa AB and Klaria Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Klaria Pharma Holding are associated (or correlated) with Nanexa AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nanexa AB has no effect on the direction of Klaria Pharma i.e., Klaria Pharma and Nanexa AB go up and down completely randomly.

Pair Corralation between Klaria Pharma and Nanexa AB

Assuming the 90 days trading horizon Klaria Pharma Holding is expected to generate 1.95 times more return on investment than Nanexa AB. However, Klaria Pharma is 1.95 times more volatile than Nanexa AB. It trades about 0.06 of its potential returns per unit of risk. Nanexa AB is currently generating about 0.07 per unit of risk. If you would invest  44.00  in Klaria Pharma Holding on August 29, 2024 and sell it today you would earn a total of  16.00  from holding Klaria Pharma Holding or generate 36.36% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Klaria Pharma Holding  vs.  Nanexa AB

 Performance 
       Timeline  
Klaria Pharma Holding 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Klaria Pharma Holding are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Klaria Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.
Nanexa AB 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Nanexa AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Nanexa AB may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Klaria Pharma and Nanexa AB Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Klaria Pharma and Nanexa AB

The main advantage of trading using opposite Klaria Pharma and Nanexa AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Klaria Pharma position performs unexpectedly, Nanexa AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nanexa AB will offset losses from the drop in Nanexa AB's long position.
The idea behind Klaria Pharma Holding and Nanexa AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Stocks Directory
Find actively traded stocks across global markets
Commodity Directory
Find actively traded commodities issued by global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges